A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
Clinical trial NCT06378177 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06378177
- Sponsor
- Lyvgen Biopharma Holdings Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-21
- Primary completion
- 2027-10-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.